The United States has begun preparations for a coronavirus vaccine. People will be vaccinated in the first half of next month. In the first stage, health workers and people at high risk of coronary heart disease will be vaccinated. The United States, the world's worst-hit country for corona infections, has seen a sharp rise in second-wave corona infections.
In the meantime, several companies have announced the launch of the Covid-19 vaccine, which is more than 90 percent effective. However, none of them have been officially approved yet. However, the US administration has already begun preparations for the distribution of the vaccine. The country's first vaccine will be launched early next month, officials said.
The U.S. administration is preparing to begin vaccinating U.S. citizens with coronavirus by mid-next month. In an announcement on Sunday, the head of the agency said corona vaccines would be given to health workers and high-risk people early next month.
The U.S. administration is preparing to begin vaccinating U.S. citizens with coronaviruses by mid-next month, Reuters reports. In an announcement on Sunday, the head of the agency said corona vaccines would be given to health workers and high-risk people early next month.
The vaccine, developed by US pharmaceutical company Pfizer Inc. and German company Bioentech, is expected to be approved by December 11, said Monsef Slaui, chief scientific officer of Operation Warp Speed, a US-led special effort to combat corona. Within 24 hours of this approval, the vaccine will be sent to different places according to the list sent from the states.
"I hope the people of the United States will start receiving the vaccine within one to two days of approval on December 11 or 12," Slauye told CNN's State of the Union program.
The vaccine, developed by US pharmaceutical company Pfizer Inc. and German company Bioentech, is expected to be approved by December 11.
The announcement of the first safe vaccine to prevent coronavirus comes from Pfizer. The company says their vaccine is 95 percent effective against corona. Soon after, Modern announced the discovery of another 95 percent effective corona vaccine. The company is also expected to seek approval for their vaccine by the end of December.
The latest announcement of another vaccine came from the British company AstraZeneca on Monday. They claim that their vaccine is 90 percent effective. According to a Reuters report, AstraZeneca's announcement has raised great hopes. Through this, people got another weapon in the fight against coronavirus. The biggest thing is that the cost of production of the vaccine made by AstraZeneca is lower than others. At the same time it can be carried easily and quickly.
According to AstraZeneca, they have shown 90 percent success in applying the vaccine they developed in a month's break to prevent Kovid-19. If approved, they will be able to bring 200 million vaccines to the market by the end of this year. And before the first quarter of 2021, they will be able to supply 600 million vaccines worldwide.
Of course, Pfizer will be the first of these three vaccines to be approved. The vaccine will be the first in the United States to be given to doctors, nurses and health workers, Reuters quoted Monsef Slawer as saying. At the same time, people with high health risks will also be vaccinated at the outset.
Note that coronavirus infections are on the rise in the United States at this time. Thanksgiving is upon us, which means the holiday season is in full swing. The United States, as always, has begun preparations for the festival. In the United States, only a quarter of the so-called corona infections have been detected since November. So far, more than 2.5 million people have died of corona in the United States. In this situation, health experts have requested everyone to take special precautions during the upcoming festival season.